JA, including its derivatives like methyl jasmonate (MJ), forms a set of oxygenated fatty acids and is a critical stimulator in their biosynthesis
Containing 0.9% benzyl alcohol, each finished batch is independently tested for sterility and supplied in a sealed 30ml borosilicate glass vial with full lot traceability
Andreeff M , Kojima K, Ruvolo V, Younes A, Wei W, Konopleva M, Duvvuri S, Huang Z, Wu L, Jukofsky L, Vassilev L, Zhi J, Geho D, Nichols G
WO2019027974A1 - COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER - Google Patents COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER Download PDF Info Publication number WO2019027974A1 WO2019027974A1 PCT/US2018/044532 US2018044532W WO2019027974A1 WO 2019027974 A1 WO2019027974 A1 WO 2019027974A1 US 2018044532 W US2018044532 W US 2018044532W WO 2019027974 A1 WO2019027974 A1 WO 2019027974A1 Authority WO WIPO (PCT) Prior art keywords whey protein subject autism composition protein isolate Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
(2002) confirmed that TSDP might indeed be a risk factor associated with ASD 27
